GlassScriptPhysician profile
Mohamed K Serio
NPI 1760432041
$1,723.60
in general payments reported to CMS, 2019-2025
10 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $19.35 · 2022: $162 · 2023: $241 · 2024: $631 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.14 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $366.26 | 2023-2025 | Pressurewire, Aveir, Gallant |
| Edwards Lifesciences Corporation | $361.20 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $321.92 | 2022-2025 | Micra, Mycarelink, Azure Xt Dr Mri Surescan |
| Heartflow, INC. | $224.73 | 2020-2025 | Ffrct |
| Medtronic Vascular, INC. | $115.64 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $111.96 | 2024 | Opsumit, Uptravi |
| Lantheus Medical Imaging, INC. | $74.11 | 2023-2024 | Definity |
| Pfizer INC. | $66.31 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.33 | 2025 | Eliquis |
| Irhythm Technologies, INC. | $28.14 | 2024 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Serio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.